2020 EACVI/JSE共识文件:心碎综合征多模式影像学检查

2020-08-28 欧洲协会心血管影像协会 Eur Heart J Cardiovasc Imaging .2020 Aug 28.

2020年8月,欧洲协会心血管影像协会(EACVI)联合日本超声心动图学会(JSE)发布了心碎综合征多模式影像学检查共识。心碎综合征是一种复杂的心脏病,临床表现广泛,至今仍认识不足。本文主要针对心碎综

中文标题:

2020 EACVI/JSE共识文件:心碎综合征多模式影像学检查

英文标题:

Multimodality imaging in takotsubo syndrome: a joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE)

发布日期:

2020-08-28

简要介绍:

2020年8月,欧洲协会心血管影像协会(EACVI)联合日本超声心动图学会(JSE)发布了心碎综合征多模式影像学检查共识。心碎综合征是一种复杂的心脏病,临床表现广泛,至今仍认识不足。本文主要针对心碎综合征多模式影像学检查的相关内容提供共识指导。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 EACVI_JSE共识文件:心碎综合征多模式影像学检查.pdf)] GetToolGuiderByIdResponse(projectId=1, id=175391c001969399, title=2020 EACVI/JSE共识文件:心碎综合征多模式影像学检查, enTitle=Multimodality imaging in takotsubo syndrome: a joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE), guiderFrom=Eur Heart J Cardiovasc Imaging .2020 Aug 28., authorId=0, author=, summary=2020年8月,欧洲协会心血管影像协会(EACVI)联合日本超声心动图学会(JSE)发布了心碎综合征多模式影像学检查共识。心碎综合征是一种复杂的心脏病,临床表现广泛,至今仍认识不足。本文主要针对心碎综, cover=https://img.medsci.cn/2020910/1599672806946_2020535.jpg, journalId=0, articlesId=null, associationId=1080, associationName=欧洲协会心血管影像协会, associationIntro=null, copyright=0, guiderPublishedTime=Fri Aug 28 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月,欧洲协会心血管影像协会(EACVI)联合日本超声心动图学会(JSE)发布了心碎综合征多模式影像学检查共识。心碎综合征是一种复杂的心脏病,临床表现广泛,至今仍认识不足。本文主要针对心碎综合征多模式影像学检查的相关内容提供共识指导。</p> </div> </div> </div>, tagList=[TagDto(tagId=58108, tagName=心碎综合征)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=58108, guiderKeyword=心碎综合征, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2089, appHits=182, showAppHits=0, pcHits=484, showPcHits=1907, likes=1, shares=8, comments=12, approvalStatus=1, publishedTime=Thu Sep 10 01:37:10 CST 2020, publishedTimeString=2020-08-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Sep 10 01:33:33 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 04:27:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 EACVI_JSE共识文件:心碎综合征多模式影像学检查.pdf)])
2020 EACVI_JSE共识文件:心碎综合征多模式影像学检查.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1073344, encodeId=4de910e334477, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/814c6321611e4ae39d5353ffccdc06c9/e1b7045038ba42eea0c8cadcb0d9c205.jpg, createdBy=5bcf5546314, createdName=a little, createdTime=Tue Nov 23 23:27:52 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898069, encodeId=2145898069d2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6635433297, createdName=ms7000000515497516, createdTime=Mon Nov 09 21:23:39 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891162, encodeId=323589116275, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d33f1698200, createdName=1de752c4m53(暂无匿称), createdTime=Sat Oct 10 22:45:37 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890939, encodeId=53fc89093982, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed0b5418103, createdName=ms3000001440468039, createdTime=Sat Oct 10 07:37:01 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888718, encodeId=baab888e1813, content=第三次听到这个病,加深印象, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b72b5126564, createdName=14648881m51暂无昵称, createdTime=Sun Sep 27 13:47:20 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2021-11-23 a little

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1073344, encodeId=4de910e334477, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/814c6321611e4ae39d5353ffccdc06c9/e1b7045038ba42eea0c8cadcb0d9c205.jpg, createdBy=5bcf5546314, createdName=a little, createdTime=Tue Nov 23 23:27:52 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898069, encodeId=2145898069d2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6635433297, createdName=ms7000000515497516, createdTime=Mon Nov 09 21:23:39 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891162, encodeId=323589116275, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d33f1698200, createdName=1de752c4m53(暂无匿称), createdTime=Sat Oct 10 22:45:37 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890939, encodeId=53fc89093982, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed0b5418103, createdName=ms3000001440468039, createdTime=Sat Oct 10 07:37:01 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888718, encodeId=baab888e1813, content=第三次听到这个病,加深印象, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b72b5126564, createdName=14648881m51暂无昵称, createdTime=Sun Sep 27 13:47:20 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2020-11-09 ms7000000515497516

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1073344, encodeId=4de910e334477, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/814c6321611e4ae39d5353ffccdc06c9/e1b7045038ba42eea0c8cadcb0d9c205.jpg, createdBy=5bcf5546314, createdName=a little, createdTime=Tue Nov 23 23:27:52 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898069, encodeId=2145898069d2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6635433297, createdName=ms7000000515497516, createdTime=Mon Nov 09 21:23:39 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891162, encodeId=323589116275, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d33f1698200, createdName=1de752c4m53(暂无匿称), createdTime=Sat Oct 10 22:45:37 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890939, encodeId=53fc89093982, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed0b5418103, createdName=ms3000001440468039, createdTime=Sat Oct 10 07:37:01 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888718, encodeId=baab888e1813, content=第三次听到这个病,加深印象, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b72b5126564, createdName=14648881m51暂无昵称, createdTime=Sun Sep 27 13:47:20 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2020-10-10 1de752c4m53(暂无匿称)

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1073344, encodeId=4de910e334477, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/814c6321611e4ae39d5353ffccdc06c9/e1b7045038ba42eea0c8cadcb0d9c205.jpg, createdBy=5bcf5546314, createdName=a little, createdTime=Tue Nov 23 23:27:52 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898069, encodeId=2145898069d2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6635433297, createdName=ms7000000515497516, createdTime=Mon Nov 09 21:23:39 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891162, encodeId=323589116275, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d33f1698200, createdName=1de752c4m53(暂无匿称), createdTime=Sat Oct 10 22:45:37 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890939, encodeId=53fc89093982, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed0b5418103, createdName=ms3000001440468039, createdTime=Sat Oct 10 07:37:01 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888718, encodeId=baab888e1813, content=第三次听到这个病,加深印象, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b72b5126564, createdName=14648881m51暂无昵称, createdTime=Sun Sep 27 13:47:20 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2020-10-10 ms3000001440468039

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1073344, encodeId=4de910e334477, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/814c6321611e4ae39d5353ffccdc06c9/e1b7045038ba42eea0c8cadcb0d9c205.jpg, createdBy=5bcf5546314, createdName=a little, createdTime=Tue Nov 23 23:27:52 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898069, encodeId=2145898069d2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6635433297, createdName=ms7000000515497516, createdTime=Mon Nov 09 21:23:39 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891162, encodeId=323589116275, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d33f1698200, createdName=1de752c4m53(暂无匿称), createdTime=Sat Oct 10 22:45:37 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890939, encodeId=53fc89093982, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed0b5418103, createdName=ms3000001440468039, createdTime=Sat Oct 10 07:37:01 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888718, encodeId=baab888e1813, content=第三次听到这个病,加深印象, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b72b5126564, createdName=14648881m51暂无昵称, createdTime=Sun Sep 27 13:47:20 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2020-09-27 14648881m51暂无昵称

    第三次听到这个病,加深印象

    0